However, current evidence strongly suggests that GLP-1 receptor agonists may be an effective treatment for improving natural conception rates and restoring spontaneous ovulation in women with metabolic disorders, especially those with PCOS. The gene discussed is GLP1R; the disease is Other metabolic disease.